Acadia Pharmaceuticals Stock
Acadia Pharmaceuticals Stock
A very strong showing by Acadia Pharmaceuticals today, with an increase of €0.71 (3.110%) compared to yesterday's price.
The stock is one of the favorites of our community with 27 Buy predictions and 1 Sell predictions.
With a target price of 27 € there is a slightly positive potential of 14.55% for Acadia Pharmaceuticals compared to the current price of 23.57 €.
Our community identified positive and negative aspects for Acadia Pharmaceuticals stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Acadia Pharmaceuticals stock. On the other hand our users think that "EBIT growth" could be a problem in the future.
Pros and Cons of Acadia Pharmaceuticals in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Acadia Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Acadia Pharmaceuticals | 3.110% | 0.047% | 12.678% | 31.089% | 33.250% | 43.297% | -52.075% |
| Ironwood Pharmaceuticals | 0.640% | -5.455% | 95.000% | -6.587% | -25.714% | -73.099% | -68.163% |
| Novocure Ltd | 2.370% | -8.174% | -3.254% | -63.646% | -65.282% | -86.701% | -91.689% |
| Iovance Biotherapeutics Inc. | 0.210% | -10.811% | 19.228% | -77.316% | -72.705% | -70.951% | -94.691% |
Comments
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Show more
Ratings data for ACAD provided by MarketBeat
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price target lowered by analysts at JPMorgan Chase & Co. from $33.00 to $31.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ACAD provided by MarketBeat
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price target lowered by analysts at Royal Bank Of Canada from $34.00 to $32.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ACAD provided by MarketBeat